Skip to content
10-K

Annual Report

MJ Pharmaceuticals Inc.

0001185185-14-000849

← back to feed
Filed
Apr 3, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Mar 26, 2014 39.89M sh
Operating Cash Flow FY 2013 · Dec 31, 2013 −$3.99K
Operating Cash Flow FY 2013 · Dec 31, 2012 −$3.14K
Total Liabilities FY 2013 · Dec 31, 2013 $0
Total Liabilities FY 2013 · Dec 31, 2012 $0
Sga Expense FY 2013 · Dec 31, 2013 $850
Sga Expense FY 2013 · Dec 31, 2013 $3.99K
Sga Expense FY 2013 · Dec 31, 2012 $3.14K
Net Income FY 2013 · Dec 31, 2013 −$3.99K
Revenue FY 2013 · Dec 31, 2013 $0
Revenue FY 2013 · Dec 31, 2013 $0
Revenue FY 2013 · Dec 31, 2012 $0
Current Liabilities FY 2013 · Dec 31, 2012 $0
Current Assets FY 2013 · Dec 31, 2012 $0
Total Assets FY 2013 · Dec 31, 2012 $0
Eps Basic FY 2013 · Dec 31, 2012 $0.00
Cash And Equivalents FY 2013 · Dec 31, 2011 $0